MI Patient Management
Importance of Lowering LDL-C inPatients With Recent MI
Speakers: Sripal Bangalore, MD, MHAAllen J. Taylor, MDRobert J. Chilton, DO, FACC, FAHADaniel Soffer, MD, FNLA
Duration: 30 minutes
Presented on: October 2, 2019
*This session is not eligible for AMA PRA Category 1 CreditsTM
Sripal Bangalore, MD, MHA
Sripal Bangalore, MD, MHADr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.
Allen J. Taylor, MD
Allen J. Taylor, MDAllen J. Taylor, MD, is Chairman of Cardiology at MedStar Heart and Vascular Institute, including Medstar Georgetown University Hospital and MedStar Washington Hospital Center in Washington, DC. Dr. Taylor is a board-certified cardiologist and clinical researcher, specializing in cardiovascular imaging and prevention. He is a member of the corporate Board of Directors for MedStar Health, the leading academic health system in the Washington DC, Maryland region.
Dr. Taylor obtained his medical training at Johns Hopkins University in Baltimore, MD, followed by internal medicine residency training at Walter Reed Army Medical Center, Washington DC, and a cardiovascular disease fellowship at the University of Virginia, Charlottesville, VA. During a 20-year career in the United States Army at Walter Reed, he served as the Director of Cardiovascular Research, Director of the Cardiovascular Disease Training Program, and Chief of the Cardiology service. He retired from military service in 2008 at the rank of Colonel, during which he held the Army's "A" proficiency designator and was decorated with the Legion of Merit. He is a full Professor of Medicine at the Uniformed University of the Health Sciences, Bethesda MD, and Georgetown University, Washington, DC.
Dr. Taylor's major research accomplishments include defining the role of lipid lowering therapy on carotid atherosclerosis, focusing on HDL cholesterol and the use of niacin. His pioneering work in the field of cardiac CT includes conducting long-term prospective outcomes trials, randomized clinical trials on the utility of the technique, and methods to enhance the safety and appropriateness of cardiovascular imaging. He has published more than 210 manuscripts in the areas of imaging, lipids, prevention, cardiovascular outcomes, and quality in journals, such as Circulation, the Journal of the American Medical Association, and the New England Journal of Medicine. He receives ongoing research funding from various federal and private sources, including the NIH. He is the author and/or editor of 5 books on topics within cardiovascular disease.
Dr. Taylor served as founding Editor-in-Chief of the Journal of Cardiovascular CT, and as Editor of the Braunwald's Heart Disease companion text atlas on cardiac CT. He is a Past President of the Society of Atherosclerosis Imaging and Prevention, and within the American College of Cardiology has held the posts of Chair of the Imaging Council, Chair of the FOCUS campaign for Appropriate Use of Cardiovascular Imaging, and member of the Board of Governors. He is a founder of the Society of Cardiovascular CT, serving on its Board of Directors from 2006-2012, and also a founder of the Certification Board of Cardiovascular CT. He serves on the board of directors for Inteleos, an organization leading certification pathways and excellence among cardiovascular imaging experts. His work on national writing groups and task forces includes multi-society guidelines on cardiac CT training, terminology, and performance, quality standards for imaging performance and radiation protection, Appropriate Use Criteria for diagnostic testing, and national standards on cardiovascular disease management and prevention.
Dr. Taylor contributes frequently to media reports as an authority on cardiovascular disease in major regional and national venues such as the Wall Street Journal, USA Today, The New York Times, US News and World Report, CNN, Associated Press, Reuters, Forbes, National Public Radio and as a frequent commentator on national video media including Good Morning America, and the NBC and CBS Nightly News programs.
Robert J. Chilton, DO, FACC, FAHA
Robert J. Chilton, DO, FACC, FAHARobert J. Chilton, DO, is an Associate Professor of Medicine and Director of the Cardiac Catheterization Laboratory at the Audie Murphy VA/ UT Health San Antonio.
A fellow of the American College of Cardiology, American College of Physicians, American College of Osteopathic Internists, and American Heart Association, Dr. Chilton also chairs the Electrophysiology Board Examination for the American Osteopathic Association and presides over the San Antonio chapters of both the Cardiovascular Society and American Heart Association.
Dr. Chilton received his Bachelor of Science degree from Philips University, Enid, Oklahoma, and his DO from the University of Osteopathic Medicine and Surgery, Des Moines, Iowa. He completed his internship at Wright-Patterson Air Force Base, Dayton, Ohio; his residency at the University of Oklahoma Health Science Center, Oklahoma City, Oklahoma; and a cardiology fellowship at the Wilford Hall United States Air Force Medical Center, San Antonio, Texas. Dr. Chilton is board certified in internal medicine, cardiovascular disease, and electrophysiology.
Over the past 20 years, Dr. Chilton has authored numerous articles, book chapters, abstracts, and presentations on cardiology. He has developed educational materials and has lectured widely, garnering several awards for his academic contributions, including 1994 Outstanding Teacher from the UT San Antonio.
Daniel Soffer, MD, FNLA
Daniel Soffer, MD, FNLADr. Soffer is a full-time clinician and Clinical Associate Professor of Medicine in the Division of General Internal Medicine and Division of Translational Medicine and Human Genetics at Perelman School of Medicine of the University of Pennsylvania. He is a lipid specialist whose clinical focus is Preventive Cardiovascular Medicine and General Internal Medicine. He is a Diplomate of the American Board of Internal Medicine and American Board of Clinical Lipidology. Dr. Soffer is involved in multiple education activities at the University of Pennsylvania, the National Lipid Association (NLA), and commercial continuing medical education as well. He is involved with many NLA activities including administration, education, meeting planning, and publishing. He is Immediate Past President (2018/2019) of the Northeast Chapter of the NLA and he is also the co-director of the Philadelphia Lipid and Atherosclerosis Club (PLAC). He is the co-Editor of LipidSpin and co-Director of the Foundations of Lipidology course for the NLA. In addition to clinical medicine and teaching, he also participates as an investigator in ongoing clinical research with lipid-modifying pharmacotherapies. He earned a BA from the University of Pennsylvania and also graduated from the University of Pennsylvania Medical School. His internship and residency were completed at the Hospital of the University of Pennsylvania.